LFG
BBH icon

Larson Financial Group’s VanEck Biotech ETF BBH Stock Holding History

Larson Financial Group’s Portfolio BBH Stock Details BBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.2K Hold
70
– – ﹤0.01% 2083
2025
Q4 		$13.2K Hold
70
– – ﹤0.01% 1957
2025
Q3 		$11.6K Hold
70
– – ﹤0.01% 1940
2025
Q2 		$10.7K Buy
+70
New +$10.4K ﹤0.01% 1781

Other funds holding BBH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
MIM
Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
CCA
Conservest Capital Advisors Wynnewood, Pennsylvania $1.1B AUM 16.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BFG
Bleakley Financial Group Fairfield, New Jersey $6.39B AUM 26.33% 1-Year Est. Return

Larson Financial Group's BBH Position: Q1 2026 in Review

Larson Financial Group held its VanEck Biotech ETF (BBH) position steady in Q1 2026 at 70 shares worth $13.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2083.

Larson Financial Group first reported a position in BBH in Q2 2025 and has held it in 4 quarters since. The position peaked at $13.2K in Q4 2025. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.

  • Larson Financial Group held 70 shares of VanEck Biotech ETF worth $13.2K as of Q1 2026.
  • Larson Financial Group left its VanEck Biotech ETF share count unchanged in Q1 2026.
  • VanEck Biotech ETF made up ﹤0.01% of Larson Financial Group's portfolio in Q1 2026, its #2083 holding.
  • Larson Financial Group first reported a position in VanEck Biotech ETF in Q2 2025 and has held it in 4 quarters since.
  • Larson Financial Group's VanEck Biotech ETF position peaked at $13.2K in Q4 2025.
  • 112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.

Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.